First China Pharmaceutical Group, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late quarterly filing notification for Q1 2013

Late annual filing notification for FY 2012

ended 09/30/12 Q3

Annual report with FYE transition – amended

ended 03/31/11 FY 2011 – amended

Prospectuses and Registrations Filter

Commission order revoking registration

Registration withdrawal request

Initial registration of new securities

Exempt offering of securities – amended

Exempt offering of securities

Ownership Filter

McTevia James V.

News Filter

Change in Certifying Accountant

Change in Certifying Accountant

Change in Certifying Accountant, Financial Statements or Exhibits

Change in Certifying Accountant, Financial Statements or Exhibits

Pharma Announces Unaudited Financials and Issues Guidance for Q2 2012 Revenues Increase 21% From 2011, Growth Remains Positive for 2012

Proxies Filter

Definitive proxy

Preliminary proxy

Other Filter

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC